{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T06:21:54Z","timestamp":1792304514822,"version":"4.4.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,3]]},"abstract":"<jats:p>Ulipristal acetate is a selective progesterone receptor modulator that acts on progesterone receptors in uterine muscle and endometrium. It is effective in reducing the size of uterine leiomyomas (fibroids) and in managing associated menorrhagia. Although ulipristal acetate\u2013associated pathologic changes have been previously documented in the endometrium, it is unclear what morphology can be expected in posttreatment fibroids. We herein report 2 cases in which patients underwent hysterectomy, after at least two 3-mo courses of ulipristal acetate. The fibroids demonstrated some pathologic changes that have previously been described associated with gonadotropin-releasing hormone agonist treatment and other progestogens. In addition, both cases demonstrated plexiform\/\u201cpatchwork\u201d fibrosis and vascular medial myxoid degeneration. Mitotic activity was absent; however, the presence of ischemic necrosis and mild nuclear atypia may mimic a more aggressive neoplasm in some areas. Awareness of these histopathologic patterns is important in the setting of ulipristal acetate treatment, to avoid over-diagnosis of \u201cuncertain malignant potential\u201d or malignant smooth muscle tumors.<\/jats:p>","DOI":"10.1097\/pgp.0000000000000581","type":"journal-article","created":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T09:03:22Z","timestamp":1549530202000},"page":"146-151","source":"Crossref","is-referenced-by-count":3,"title":["Pathologic Changes in Uterine Leiomyomas After Extended Treatment With Ulipristal Acetate"],"prefix":"10.1097","volume":"39","author":[{"given":"Martin C.","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor","family":"Latta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230824","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/01.AOG.0000136079.62513.39","article-title":"Uterine myomas: an overview of development, clinical features, and management","volume":"104","author":"Wallach","year":"2004","journal-title":"Obstet Gynecol"},{"key":"R2-20230824","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/humrep\/17.6.1424","article-title":"What are the implications of myomas on fertility? A need for a debate?","volume":"17","author":"Donnez","year":"2002","journal-title":"Hum Reprod"},{"key":"R3-20230824","first-page":"1217","article-title":"An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial","volume":"76","author":"Carr","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"R4-20230824","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJMoa1103182","article-title":"Ulipristal acetate versus placebo for fibroid treatment before surgery","volume":"366","author":"Donnez","year":"2012","journal-title":"N Engl J Med"},{"key":"R5-20230824","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2147\/CEOR.S78115","article-title":"Incorporating ulipristal acetate in the care of symptomatic uterine fibroids: a Canadian cost-utility analysis of pharmacotherapy management","volume":"7","author":"Tsoi","year":"2015","journal-title":"Clinicoecon Outcomes Res"},{"key":"R6-20230824","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1210\/jc.2006-2816","article-title":"Effects of the progesterone receptor modulator VA2914 in a continuous low dose on the hypothalamic-pituitary-ovarian axis and endometrium in normal women: a prospective, randomized, placebo-controlled trial","volume":"92","author":"Chabbert-Buffet","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R7-20230824","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0303-7207(01)00743-2","article-title":"CDB-4124 and its putative monodemethylated metabolite, CDB-4453, are potent antiprogestins with reduced antiglucocorticoid activity: in vitro comparison to mifepristone and CDB-2914","volume":"188","author":"Attardi","year":"2002","journal-title":"Mol Cell Endocrinol"},{"key":"R8-20230824","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.mce.2011.05.044","article-title":"The role of progesterone signaling in the pathogenesis of uterine leiomyoma","volume":"358","author":"Kim","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"R9-20230824","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/jcp.2011.089664","article-title":"Unusual morphological features of uterine leiomyomas treated with progestogens","volume":"64","author":"Boyd","year":"2011","journal-title":"J Clin Pathol"},{"key":"R10-20230824","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00004347-199704000-00008","article-title":"Histology of leiomyomata in patients treated with leuprolide acetate","volume":"16","author":"Demopoulos","year":"1997","journal-title":"Int J Gynecol Pathol"},{"key":"R11-20230824","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/PGP.0b013e318251035b","article-title":"Endometrial morphology after treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetate","volume":"31","author":"Williams","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"R12-20230824","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/00004347-198809000-00002","article-title":"Hemorrhagic cellular leiomyomas (\u201capolectic leiomyoma\u201d) of the uterus associated with pregnancy and oral contraceptives","volume":"7","author":"Norris","year":"1988","journal-title":"Int J Gynecol Pathol"},{"key":"R13-20230824","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00000478-199201000-00004","article-title":"Diffuse, perinodular, and other patterns of hydropic degeneration within and adjacent to uterine leiomyomas. Problems in differential diagnosis","volume":"16","author":"Clement","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"R14-20230824","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jmig.2016.08.004","article-title":"Unexpected uterine leiomyosarcoma during laparoscopic hysterectomy treated 6 months with ulipristal acetate and contained power morcellation","volume":"24","author":"Istre","year":"2017","journal-title":"J Minim Invasive Gynecol"},{"key":"R15-20230824","doi-asserted-by":"crossref","first-page":"e11532","DOI":"10.1097\/MD.0000000000011532","article-title":"Failure of ulipristal acetate treatment as an indication for uterine malignancy. Two case reports","volume":"97","author":"Santoro","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"R16-20230824","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.rbmo.2018.04.040","article-title":"Ulipristal acetate for the management of large uterine fibroids associated with heavy bleeding: a review","volume":"37","author":"Donnez","year":"2018","journal-title":"Reprod Biomed Online"}],"container-title":["International Journal of Gynecological Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000000581","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T01:43:53Z","timestamp":1692841433000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000000581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/pgp.0000000000000581","relation":{},"ISSN":["0277-1691"],"issn-type":[{"value":"0277-1691","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]}}}